Tycoon Group Holdings Limited
3390.HKHKSEHealthcareMedical - Pharmaceuticals
Latest quote
HK$0.255
HK$0.00 · 0.00%
3390.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteTycoon Group Holdings Limited functions as an investment holding enterprise, specializing in the worldwide distribution and retail of an extensive portfolio of health and wellness products. Its market presence extends across Hong Kong, Mainland China, Macau, and various international regions. The company's operations are divided into three distinct divisions: Distribution, E-Commerce, and physical Retail Stores. It offers a diverse selection of goods, including traditional Chinese medicine, nutritional supplements, skincare, personal care items, and other healthcare solutions, sold under both its proprietary labels and third-party brands. Sales channels encompass wholesale distribution to major chain retailers, independent stores, and traders, alongside direct-to-consumer sales through its own network of brick-and-mortar shops and digital platforms. Founded in 2015, the firm is based in Shatin, Hong Kong.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- Headquarters
- HK
- CEO
- Ka Chun Wong
- Listed since
- Apr 15, 2020
- Employees
- 177
Market position
Day range
Current HK$0.255
52-week range
Current HK$0.255
- Open
- HK$0.255
- Previous close
- HK$0.255
- Volume
- 56K
- 0.08× average
- Average volume
- 677.18K
- Average daily volume
- Market cap
- 227.97M HKD
- Beta
- -0
- Market reference 1
- 50-day average
- HK$0.2397
- +6.37% above average
- 200-day average
- HK$0.272
- -6.25% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 595.96M HKD
- P/E (TTM)
- 14.57×
- P/B (TTM)
- 0.41×
- P/S (TTM)
- 0.21×
- EV / EBITDA
- 10.66×
- Earnings yield
- 6.58%
- Free cash flow yield
- 40.49%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 24.62%
- Operating margin
- 3.97%
- Net margin
- 1.43%
- Return on equity
- 2.92%
- Return on assets
- 1.34%
- Return on invested capital
- 3.93%
Financial health
- Debt / equity
- 0.8×
- Current ratio
- 1.4×
- Altman Z-score
- 2.73
- Piotroski F-score
- 3 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (HKD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.1B HKD | 876.04M HKD | 1.2B HKD | 1.19B HKD | 888.87M HKD |
| Cost of goods sold | 826.6M HKD | 643.38M HKD | 877.55M HKD | 942.66M HKD | 753.86M HKD |
| Gross profit | 270.04M HKD | 232.66M HKD | 321.1M HKD | 243.53M HKD | 135.01M HKD |
| Selling, general, and administrative | 230.79M HKD | 205.2M HKD | 193.05M HKD | 194.3M HKD | 162.36M HKD |
| Operating expenses | 226.51M HKD | 202.66M HKD | −15.45M HKD | 196.66M HKD | 159.48M HKD |
| Interest income | 70K HKD | 844K HKD | 207K HKD | 42K HKD | — |
| Interest expense | 22.04M HKD | 20.48M HKD | 23.42M HKD | 11.32M HKD | 6.26M HKD |
| Depreciation and amortization | 14M HKD | 7.76M HKD | 19.86M HKD | 18.01M HKD | 16.69M HKD |
| Operating income | 43.53M HKD | 30M HKD | 336.55M HKD | 64.88M HKD | −9.66M HKD |
| Net income | 15.67M HKD | 3.24M HKD | 297.32M HKD | 43.75M HKD | −18.82M HKD |
Company facts updated Aug 25, 2026.
Earnings
- Latest EPS result
- -0.02
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
3390.HK peers
Continue in GoAI
Research 3390.HKresearch.disclaimer